Correlation Between Cue Biopharma and Viracta Therapeutics
Can any of the company-specific risk be diversified away by investing in both Cue Biopharma and Viracta Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cue Biopharma and Viracta Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cue Biopharma and Viracta Therapeutics, you can compare the effects of market volatilities on Cue Biopharma and Viracta Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cue Biopharma with a short position of Viracta Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cue Biopharma and Viracta Therapeutics.
Diversification Opportunities for Cue Biopharma and Viracta Therapeutics
-0.3 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Cue and Viracta is -0.3. Overlapping area represents the amount of risk that can be diversified away by holding Cue Biopharma and Viracta Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Viracta Therapeutics and Cue Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cue Biopharma are associated (or correlated) with Viracta Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Viracta Therapeutics has no effect on the direction of Cue Biopharma i.e., Cue Biopharma and Viracta Therapeutics go up and down completely randomly.
Pair Corralation between Cue Biopharma and Viracta Therapeutics
Considering the 90-day investment horizon Cue Biopharma is expected to generate 1.63 times more return on investment than Viracta Therapeutics. However, Cue Biopharma is 1.63 times more volatile than Viracta Therapeutics. It trades about 0.0 of its potential returns per unit of risk. Viracta Therapeutics is currently generating about -0.18 per unit of risk. If you would invest 208.00 in Cue Biopharma on September 3, 2024 and sell it today you would lose (86.00) from holding Cue Biopharma or give up 41.35% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cue Biopharma vs. Viracta Therapeutics
Performance |
| Timeline |
| Cue Biopharma |
| Viracta Therapeutics |
Cue Biopharma and Viracta Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cue Biopharma and Viracta Therapeutics
The main advantage of trading using opposite Cue Biopharma and Viracta Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cue Biopharma position performs unexpectedly, Viracta Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Viracta Therapeutics will offset losses from the drop in Viracta Therapeutics' long position.| Cue Biopharma vs. DiaMedica Therapeutics | Cue Biopharma vs. Lyra Therapeutics | Cue Biopharma vs. Centessa Pharmaceuticals PLC |
| Viracta Therapeutics vs. Vincerx Pharma | Viracta Therapeutics vs. Rallybio Corp | Viracta Therapeutics vs. Tenaya Therapeutics | Viracta Therapeutics vs. Lyra Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Complementary Tools
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |